Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $66.4600 (0.74%) ($66.0800 - $66.9300) on Mon. Aug. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.46% (three month average) | RSI | 57 | Latest Price | $66.4600(0.74%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) VYM(53%) DIA(52%) SPLV(52%) IVE(51%) | Factors Impacting ABBV price | ABBV will decline at least -1.23% in a week (0% probabilities). VIXM(-37%) VXX(-15%) TLT(-15%) IFRA(-13%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.23% (StdDev 2.46%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $66.78(-0.48%) | 10 Day Moving Average | $65.71(1.14%) | 20 Day Moving Average | $65.58(1.34%) | To recent high | -15.8% | To recent low | 5.5% | Market Cap | $117.254b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |